Sequent Scientific Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sequent Scientific Ltd. on BSE

Load latest

Sequent Scientific Ltd.

28 Nov 2023

194.90

4.62%

Company Update

SEQUENT SCIENTIFIC LTD. - 512529 - Clarification sought from Sequent Scientific Ltd

BSE India

The Exchange has sought clarification from Sequent Scientific Ltd on November 28, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Sequent Scientific Ltd.

13 Nov 2023

194.90

4.62%

Earnings Call

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.

pdf

Sequent Scientific Ltd.

08 Nov 2023

194.90

4.62%

Company Update

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of Unaudited Financials (Standalone and Consolidated) for Quarter and Half Year ended September 30 2023

pdf

Sequent Scientific Ltd.

07 Nov 2023

194.90

4.62%

Earnings Call

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

The audio recording of the earnings call and earnings presentation made on November 07, 2023, on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2023, is available on the Company's website.

pdf

Sequent Scientific Ltd.

06 Nov 2023

194.90

4.62%

Investor Presentation

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor presentation on Unaudited standalone and consolidated financials of quarter and half year ended September 30, 2023

pdf

Sequent Scientific Ltd.

06 Nov 2023

194.90

4.62%

Company Update

SEQUENT SCIENTIFIC LTD. - 512529 - Appointment Of Chief Financial Officer Of The Company

BSE India

Appointment of Mr. Saurav Bhala as Chief Financial Officer of the Company

pdf

Sequent Scientific Ltd.

06 Nov 2023

194.90

4.62%

Board Meeting

SEQUENT SCIENTIFIC LTD. - 512529 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its Meeting held today, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2023. In this regard, kindly find enclosed the following: 1. Unaudited Consolidated Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and half year ended September 30, 2023. 2. Unaudited Standalone Financial Results along with Independent Auditor's Review Report issued by the Statutory Auditors of the Company for the quarter and half year ended September 30, 2023. The Board Meeting commenced at 08:15 p.m. and concluded at 09:55 p.m.

pdf

Sequent Scientific Ltd.

06 Nov 2023

194.90

4.62%

Result

SEQUENT SCIENTIFIC LTD. - 512529 - Outcome Of Board Meeting Held On November 06, 2023 Along …

BSE India

Disclosure of unaudited consolidated and standalone financial results for quarter and half year ended September 30, 2023

pdf

Sequent Scientific Ltd.

03 Nov 2023

194.90

4.62%

Company Update

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

India Ratings and Research vide its letter dated November 02, 2023 has revised the Company''s rating on long-term and short-term bank facilities. The Rating letter is enclosed herewith for your reference and record.

pdf

Sequent Scientific Ltd.

30 Oct 2023, 06:43PM

194.90

4.62%

Company Update

SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has, as a part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Tuesday, November 07, 2023, to discuss its Q2FY24 financial results.

pdf

Is Sequent Scientific Ltd. worth buying?

316 Votes:

Buy 81.65%

Sell 11.08%

Hold 7.28%